Top of the morning to you, and a fine one it is. Our short person has scampered off to the local schoolhouse for a fresh round of testing and our official mascot is happily snoozing in his official snoozing corner. As for us, we are enjoying a few rays of relatively warm sunshine enveloping the Pharmalot campus and, not surprisingly, brewing a few cups of stimulation. Our choice today is the intriguing white chocolate peppermint, for those who follow this sort of thing. Meanwhile, here are some tidbits to stimulate your own neurons. Hope today goes well and you conquer the world.

The debate over creating a single government health plan for all Americans may be dominating the Democratic presidential campaign, but most voters are focused more on prescription drug prices, The Los Angeles Times reports. In one recent poll, two-thirds of Iowa voters identified prescription drug costs as the most significant health care concern, matched only by worries about overall out-of-pocket healthcare costs. Similar sentiment was seen among voters in New Hampshire and South Carolina, whose primaries follow the Iowa caucuses.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy